Matthew A. Wyczalkowski

Washington University in St. Louis — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

42h-index16.1kcitations149works4.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(41), Multiple Myeloma Research and Treatments(35), Renal cell carcinoma treatment(23), Protein Degradation and Inhibitors(17), Ferroptosis and cancer prognosis(13)

Publications141 total

Supplementary Figures from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
2025Open Access
Table S3 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
2025Open Access
Table S2 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
2025Open Access
Table S1 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
2025Open Access
Table S6 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
2025Open Access
Table S4 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
2025Open Access
Table S5 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
2025Open Access
Abstract 305: Cellular senescence in human liver under normal aging and cancer
Cancer Research·2025
Abstract 2555: Multimodal atlas of cellular senescence in human bone marrow reveals insights into aging and multiple myeloma
Cancer Research·2025
Differential chromatin accessibility and transcriptional dynamics define breast cancer subtypes and their lineages
Nature Cancer·2024· 19 citedOpen Access
Treatment resistance to melanoma therapeutics on a single cell level
Scientific Reports·2024· 1 citedOpen Access
Supplementary Figures from Single-cell discovery and multi-omic characterization of therapeutic targets in multiple myeloma
2024Open Access
Table S6 from Single-cell discovery and multi-omic characterization of therapeutic targets in multiple myeloma
2024Open Access
Supplementary Figures from Single-cell discovery and multi-omic characterization of therapeutic targets in multiple myeloma
2024Open Access
Table S1 from Single-cell discovery and multi-omic characterization of therapeutic targets in multiple myeloma
2024Open Access
Table S4 from Single-cell discovery and multi-omic characterization of therapeutic targets in multiple myeloma
2024Open Access
Table S3 from Single-cell discovery and multi-omic characterization of therapeutic targets in multiple myeloma
2024Open Access
Table S5 from Single-cell discovery and multi-omic characterization of therapeutic targets in multiple myeloma
2024Open Access
Data from Single-cell discovery and multi-omic characterization of therapeutic targets in multiple myeloma
2024Open Access
Table S2 from Single-cell discovery and multi-omic characterization of therapeutic targets in multiple myeloma
2024Open Access
page 1 of 8Next →

Frequent Co-authors

Li Ding(41), Michael C. Wendl(28), Song Cao(21), David Fenyö(18), Henry Rodriguez(17), Yige Wu(16), Reyka G. Jayasinghe(16), Yize Li(16), Ana I. Robles(16), Daniel Cui Zhou(15), Mathangi Thiagarajan(15), Antonio Colaprico(14), Mehdi Mesri(14), Bing Zhang(14), Gad Getz(13), D.R. Mani(13), Chet Birger(13), David I. Heiman(12), Pei Wang(12), Alexey I. Nesvizhskii(12)